{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:18:09Z","timestamp":1791227889428,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["N42A650352"],"award-info":[{"award-number":["N42A650352"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["MU-SRF-RS-05A\/67"],"award-info":[{"award-number":["MU-SRF-RS-05A\/67"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178233","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:32:24Z","timestamp":1760070744000},"page":"178233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-\u03baB pathways"],"prefix":"10.1016","volume":"1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-2398","authenticated-orcid":false,"given":"Hnin Ei Ei","family":"Khine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3223-1551","authenticated-orcid":false,"given":"Supachoke","family":"Mangmool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-2477","authenticated-orcid":false,"given":"Warisara","family":"Parichatikanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178233_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/15569527.2020.1844727","article-title":"Exendin-4 inhibits high glucose-induced oxidative stress in retinal pigment epithelial cells by modulating the expression and activation of p66Shc","volume":"40","author":"Al Sabaani","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178233_bib2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cbf.3795","article-title":"The cardioprotective effect of human glucagon\u2010like peptide\u20101 receptor agonist (semaglutide) on cisplatin\u2010induced cardiotoxicity in rats: targeting mitochondrial functions, dynamics, biogenesis, and redox status pathways","volume":"41","author":"Atef","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejphar.2025.178233_bib3","doi-asserted-by":"crossref","first-page":"26115","DOI":"10.1074\/jbc.M313509200","article-title":"p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1","volume":"279","author":"Bohuslav","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178233_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10557-010-6242-z","article-title":"Neonatal exendin-4 leads to protection from reperfusion injury and reduced rates of oxidative phosphorylation in the adult rat heart","volume":"24","author":"Brown","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2025.178233_bib6","first-page":"520","article-title":"Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1\/PGC1\u03b1","volume":"38","author":"Cai","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2025.178233_bib7","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-020-03524-9","article-title":"P53 vs NF-\u03baB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa","volume":"77","author":"Carr\u00e0","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib8","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jcp.22599","article-title":"Analysis of p53 and NF-kappaB signaling in modulating the cardiomyocyte fate during hypertrophy","volume":"226","author":"Chatterjee","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib9","first-page":"3669","article-title":"Exendin-4 inhibits atrial arrhythmogenesis in a model of myocardial infarction-induced heart failure via the GLP-1 receptor signaling pathway","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cvr\/cvp181","article-title":"Mitochondrial OPA1, apoptosis, and heart failure","volume":"84","author":"Chen","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/tox.22552","article-title":"NF-\u03baB\/p53-activated inflammatory response involves in diquat-induced mitochondrial dysfunction and apoptosis","volume":"33","author":"Choi","year":"2018","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178233_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135083","article-title":"Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178233_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-230859","article-title":"Mitochondrial fusion promoter given during ischemia has greater neuroprotective efficacy than when given at onset of reperfusion in rats with cardiac ischemia\/reperfusion injury","volume":"97","author":"Chunchai","year":"2024","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.ejphar.2025.178233_bib14","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.3390\/ijms22105303","article-title":"Mechanisms of beta-cell apoptosis in type 2 diabetes-prone situations and potential protection by GLP-1-based therapies","volume":"22","author":"Costes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib15","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2025.178233_bib16","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms23179583","article-title":"Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib17","doi-asserted-by":"crossref","first-page":"C270","DOI":"10.1152\/ajpcell.00194.2015","article-title":"Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts","volume":"310","author":"Du","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tox.2016.10.001","article-title":"An integrative view of cisplatin-induced renal and cardiac toxicities: molecular mechanisms, current treatment challenges and potential protective measures","volume":"371","author":"Dugbartey","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2025.178233_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12012-020-09567-5","article-title":"Exendin-4 ameliorates cardiac remodeling in experimentally induced myocardial infarction in rats by inhibiting PARP1\/NF-\u03baB axis in a SIRT1-dependent mechanism","volume":"20","author":"Eid","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178233_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12265-020-09984-5","article-title":"Exendin-4 protects against myocardial ischemia-reperfusion injury by upregulation of SIRT1 and SIRT3 and activation of AMPK","volume":"14","author":"Eid","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1440-1681.13299","article-title":"Exendin\u20104 protects the hearts of rats from ischaemia\/reperfusion injury by boosting antioxidant levels and inhibition of JNK\/p66Shc\/NADPH axis","volume":"47","author":"Eid","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/ijms20071599","article-title":"NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases","volume":"20","author":"Fiordelisi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925738","article-title":"p53\/sirtuin 1\/NF-\u03baB signaling axis in chronic inflammation and maladaptive kidney repair after cisplatin nephrotoxicity","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178233_bib24","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-025-02607-w","article-title":"The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)","volume":"24","author":"Hullon","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2025.178233_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","article-title":"Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178233_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10863-017-9705-0","article-title":"Role of FOXO transcription factors in crosstalk between mitochondria and the nucleus","volume":"49","author":"Kim","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ejphar.2025.178233_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-008-9929-8","article-title":"Prevalent role of Akt and ERK activation in cardioprotective effect of Ca2+ channel- and beta-adrenergic receptor blockers","volume":"321","author":"Kovacs","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2025.178233_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178233_bib30","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.3892\/mmr.2017.6978","article-title":"Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2025.178233_bib31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/jcmm.12272","article-title":"The stem cell adjuvant with exendin\u20104 repairs the heart after myocardial infarction via STAT 3 activation","volume":"18","author":"Liu","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12192-023-01321-4","article-title":"Novel insights into the involvement of mitochondrial fission\/fusion in heart failure: from molecular mechanisms to targeted therapies","volume":"28","author":"Liu","year":"2023","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.ejphar.2025.178233_bib33","first-page":"778","article-title":"Exendin-4 therapy still offered an additional benefit on reducing transverse aortic constriction-induced cardiac hypertrophy-caused myocardial damage in DPP-4 deficient rats","volume":"8","author":"Lu","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178233_bib35","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.7150\/ijbs.59965","article-title":"GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential","volume":"17","author":"Ma","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib36","first-page":"77","article-title":"Inhibition of nuclear factor kappa B pathway protects myocardial ischemia\/reperfusion injury in rats under treatment with abnormal savda munziq","volume":"10","author":"Maimaitiaili","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/me.2014-1346","article-title":"Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes","volume":"29","author":"Mangmool","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.178233_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116175","article-title":"Stimulation of adenosine A1 receptor prevents oxidative injury in H9c2 cardiomyoblasts: role of G\u03b2\u03b3-mediated Akt and ERK1\/2 signaling","volume":"451","author":"Mangmool","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","article-title":"How ERK1\/2 activation controls cell proliferation and cell death: is subcellular localization the answer?","volume":"8","author":"Mebratu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2025.178233_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib41","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1111\/bph.14431","article-title":"Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials","volume":"176","author":"Nguyen","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fphar.2020.00805","article-title":"Stimulation of GLP-1 receptor inhibits methylglyoxal-induced mitochondrial dysfunctions in H9c2 cardiomyoblasts: potential role of Epac\/PI3K\/Akt pathway","volume":"11","author":"Nuamnaichati","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms19010026","article-title":"Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling","volume":"19","author":"Oh","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib44","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","article-title":"Inhibiting mitochondrial fission protects the heart against ischemia\/reperfusion injury","volume":"121","author":"Ong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178233_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/cvr\/cvq237","article-title":"Mitochondrial morphology and cardiovascular disease","volume":"88","author":"Ong","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib46","first-page":"1","article-title":"Alteration in cardiac PI3K\/Akt\/mTOR and ERK signaling pathways with the use of growth hormone and swimming, and the roles of miR21 and miR133","volume":"10","author":"Palabiyik","year":"2019","journal-title":"Biomed. Rep"},{"key":"10.1016\/j.ejphar.2025.178233_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213816","article-title":"High glucose-induced cardiomyocyte damage involves interplay between endothelin ET-1\/ETA\/ETB receptor and mTOR pathway","volume":"23","author":"Pandey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178233_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175896","article-title":"Exendin-4 protects against high glucose-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y neuroblastoma cells through GLP-1 receptor\/Epac\/Akt signaling","volume":"954","author":"Pandey","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116552","article-title":"Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: potential role of GLP-1 receptor and mTOR signaling","volume":"229","author":"Parichatikanond","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10715762.2022.2067042","article-title":"Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1\/Nrf2 signaling pathway","volume":"56","author":"Qi","year":"2022","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-015-0476-7","article-title":"Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix","volume":"110","author":"Robinson","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.235","article-title":"Mitochondrial fission: a drug target for cytoprotection or cytodestruction?","volume":"4","author":"Rosdah","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejphar.2025.178233_bib53","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/35009130","article-title":"Role of NF-\u03baB in p53-mediated programmed cell death","volume":"404","author":"Ryan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178233_bib54","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/ars.2021.0145","article-title":"Mitochondrial fusion, fission, and mitophagy in cardiac diseases: challenges and therapeutic opportunities","volume":"36","author":"Scheffer","year":"2022","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.178233_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1164166","article-title":"The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases","volume":"11","author":"Song","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178233_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.freeradbiomed.2022.01.024","article-title":"T3-induced enhancement of mitochondrial Ca2+ uptake as a boost for mitochondrial metabolism","volume":"181","author":"Tawfik","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcdb.2024.01.006","article-title":"Super-resolution microscopies, technological breakthrough to decipher mitochondrial structure and dynamic","volume":"159\u2013160","author":"Teixeira","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178233_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2007.04.006","article-title":"p53 and NF-kappaB crosstalk: IKKalpha tips the balance","volume":"26","author":"Tergaonkar","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178233_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.905072","article-title":"Current understanding of the pivotal role of mitochondrial dynamics in cardiovascular diseases and senescence","volume":"9","author":"Uchikado","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib60","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.freeradbiomed.2023.09.036","article-title":"p53 contributes to cardiovascular diseases via mitochondria dysfunction: a new paradigm","volume":"208","author":"Wang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.178233_bib61","article-title":"Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178233_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8905917","article-title":"Exendin\u20104 protects against hyperglycemia\u2010induced cardiomyocyte pyroptosis via the AMPK\u2010TXNIP pathway","volume":"2019","author":"Wei","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2025.178233_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yjmcc.2014.08.022","article-title":"Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes","volume":"76","author":"Younce","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178233_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5396806","article-title":"Exendin-4 and liraglutide attenuate glucose toxicity-induced cardiac injury through mTOR\/ULK1-dependent autophagy","volume":"2018","author":"Yu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.178233_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109252","article-title":"GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1\u03b2-induced metabolic disturbance and mitochondrial dysfunction","volume":"332","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.178233_bib66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12891-024-07640-6","article-title":"Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.ejphar.2025.178233_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1139\/bcb-2021-0365","article-title":"Cardiovascular protective effects of GLP-1: a focus on the MAPK signaling pathway","volume":"100","author":"Zhao","year":"2022","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejphar.2025.178233_bib68","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178233_bib69","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Investig."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:27:58Z","timestamp":1779323278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"alternative-id":["S0014299925009872"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178233","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-\u03baB pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178233"}}